Literature DB >> 16861933

The impact of memory T cells on rejection and the induction of tolerance.

Matthew O Brook, Kathryn J Wood, Nick D Jones.   

Abstract

Accumulating evidence suggests that alloreactive memory T cells (Tm) may be generated in transplant recipients that have not previously been exposed to alloantigen through mechanisms such as cross-reactivity and homeostatic proliferation. The presence of Tm correlates with both acute and chronic rejection episodes and, furthermore, may be responsible for the failure to induce tolerance in large animal and clinical settings. A clearer understanding of how Tm function and their requirements to mount an effective response to alloantigen will be key to further attempts to translate tolerance induction protocols from the experimental setting to the clinic.

Entities:  

Mesh:

Year:  2006        PMID: 16861933     DOI: 10.1097/01.tp.0000226082.17507.da

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  43 in total

1.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

2.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

Review 3.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 4.  Inflammation and transplantation tolerance.

Authors:  Daniel R Goldstein
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

5.  Characteristics of alloreactive T cells measured before renal transplantation.

Authors:  P J E J van de Berg; S L Yong; S D Koch; N Lardy; K A M I van Donselaar-van der Pant; S Florquin; F J Bemelman; R A W van Lier; I J M ten Berge
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

6.  B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

Authors:  V Gorbacheva; K Ayasoufi; R Fan; W M Baldwin; A Valujskikh
Journal:  Am J Transplant       Date:  2014-12-12       Impact factor: 8.086

Review 7.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

8.  Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Kartika Jayashankar; Sierra F Garcia; Mahmoud Abdel-Rasoul; Nico van Rooijen; Ginny L Bumgardner
Journal:  Cell Transplant       Date:  2012-10-11       Impact factor: 4.064

9.  Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.

Authors:  Jurjen H Velthuis; Wendy W Unger; Joana R F Abreu; Gaby Duinkerken; Kees Franken; Mark Peakman; Arnold H Bakker; Sine Reker-Hadrup; Bart Keymeulen; Jan Wouter Drijfhout; Ton N Schumacher; Bart O Roep
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

10.  Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortium.

Authors:  I Ashoor; N Najafian; Y Korin; E F Reed; T Mohanakumar; D Ikle; P S Heeger; M Lin
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.